1. Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial. (13th August 2018) Authors: Pathak, Sanjeev; Vince, Bradley; Kelsh, Debra; Shram, Megan J.; Setnik, Beatrice; Lu, Hong; Nangia, Narinder; Stanford, Arielle D.; Ehrich, Elliot Journal: Journal of clinical pharmacology Issue: Volume 59:Number 2(2019) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abuse Potential of Samidorphan: A Phase I, Oxycodone‐, Pentazocine‐, Naltrexone‐, and Placebo‐Controlled Study. (26th November 2018) Authors: Pathak, Sanjeev; Vince, Bradley; Kelsh, Debra; Setnik, Beatrice; Nangia, Narinder; DiPetrillo, Lauren; Puhl, Matthew D.; Sun, Lei; Stanford, Arielle D.; Ehrich, Elliot Journal: Journal of clinical pharmacology Issue: Volume 59:Number 2(2019) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of the Opioid System Modulator, Samidorphan, on Measures of Alcohol Consumption and Patient‐Reported Outcomes in Adults with Alcohol Dependence. (13th August 2018) Authors: O'Malley, Stephanie S.; Todtenkopf, Mark S.; Du, Yangchun; Ehrich, Elliot; Silverman, Bernard L. Journal: Alcoholism Issue: Volume 42:Number 10(2018) Page Start: 2011 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Use of Remifentanil in a Novel Clinical Paradigm to Characterize Onset and Duration of Opioid Blockade by Samidorphan, a Potent μ-Receptor Antagonist. Issue 3 (June 2015) Authors: Shram, Megan J.; Silverman, Bernard; Ehrich, Elliot; Sellers, Edward M.; Turncliff, Ryan Journal: Journal of clinical psychopharmacology Issue: Volume 35:Issue 3(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Use of Remifentanil in a Novel Clinical Paradigm to Characterize Onset and Duration of Opioid Blockade by Samidorphan, a Potent μ-Receptor Antagonist. Issue 3 (June 2015) Authors: Shram, Megan J.; Silverman, Bernard; Ehrich, Elliot; Sellers, Edward M.; Turncliff, Ryan Journal: Journal of clinical psychopharmacology Issue: Volume 35:Issue 3(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗